Loading…
A critical role of farnesol in the modulation of Amphotericin B and Aureobasidin A antifungal drug susceptibility
Candida albicans and its related species can cause opportunistic infections such as "candidiasis" in immunocompromised individuals with a high morbidity and mortality rate. Several antifungal drugs available in the market are often used to treat infections caused by pathogenic fungi. Howev...
Saved in:
Published in: | Mycology 2022-10, Vol.13 (4), p.305-317 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c539t-79a4a0896f39ecc7b3ee5325282b8a338c473c16274c5531c40f737336eab6d73 |
---|---|
cites | cdi_FETCH-LOGICAL-c539t-79a4a0896f39ecc7b3ee5325282b8a338c473c16274c5531c40f737336eab6d73 |
container_end_page | 317 |
container_issue | 4 |
container_start_page | 305 |
container_title | Mycology |
container_volume | 13 |
creator | Mahendrarajan, Venkatramanan Bari, Vinay Kumar |
description | Candida albicans and its related species can cause opportunistic infections such as "candidiasis" in immunocompromised individuals with a high morbidity and mortality rate. Several antifungal drugs available in the market are often used to treat infections caused by pathogenic fungi. However, in fungi, the development of resistance against these drugs quickly evolved. Candida is a dimorphic fungus that can switch between yeast to hyphae form, requires an active biosynthesis of membrane constituents. Sphingolipid and ergosterol molecules, are the major fungal plasma membrane components, and their interaction with the antifungal drug can modulate drug susceptibility. A lipophilic compound farnesol acts as a quorum-sensing molecule synthesised by the isoprenoid biosynthesis pathway in the fungal pathogen Candida. Farnesol is secreted in a cell density-dependent manner inhibits hyphae germination and biofilm formation. In this study, we have investigated whether the farnesol molecules affect the drug susceptibility of the antifungal drug Amphotericin B (AmB) which mainly binds with ergosterol, and Aureobasidin A (AbA), a complex sphingolipid biosynthesis inhibitor. Our studies revealed that a non-toxic and low concentration of farnesol can reduce the efficacy of AmB and AbA on yeast cells. This reduction is probably through the alteration in the complex sphingolipid biosynthesis and ATP-binding cassette (ABC) type membrane transport activity. These findings may shed light on a new direction to explore the role of lipid molecules in the antifungal drug resistance mechanisms in pathogenic yeast. |
doi_str_mv | 10.1080/21501203.2022.2138599 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b14a6571246741e8b57330f2c055955c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b14a6571246741e8b57330f2c055955c</doaj_id><sourcerecordid>3092107787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c539t-79a4a0896f39ecc7b3ee5325282b8a338c473c16274c5531c40f737336eab6d73</originalsourceid><addsrcrecordid>eNp9kk2LFDEQhhtRcFn3JwgBL15mzGencxHbxY-FBS96DtXp9EyGdDKbpJX596adcWE9mEvCW1VPqoq3aV4TvCW4w-8oEZhQzLYUU7qlhHVCqWfN1apvCCXk-eMbs5fNTc4HXA-jCrfiqnnokUmuOAMepegtihOaIAWbo0cuoLK3aI7j4qG4GNZoPx_3sdjkTA1_RBBG1C_JxgGyG6vUV6m4aQm7ihzTskN5ycYeixucd-X0qnkxgc_25nJfNz8-f_p--3Vz_-3L3W1_vzGCqbKRCjjgTrUTU9YYOTBrBaOCdnTogLHOcMkMaankRghGDMeTZJKx1sLQjpJdN3dn7hjhoI_JzZBOOoLTf4SYdhpSHdxbPRAOrZCE8lZyYrtBVA6eqMFCKCFMZb0_s47LMNvR2FAS-CfQp5Hg9noXf2rV1p4UrYC3F0CKD4vNRc-uLsV7CDYuWVPJOq44b0VNffNP6iEuKdRVaYYVJVjKbp1OnLNMijknOz02Q7BejaH_GkOvxtAXY9S6D-c6F6aYZvgVkx91gZOPaUoQjKvf_B_xG_cfvlk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3092107787</pqid></control><display><type>article</type><title>A critical role of farnesol in the modulation of Amphotericin B and Aureobasidin A antifungal drug susceptibility</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Taylor & Francis Journals</source><source>IngentaConnect Journals</source><source>PubMed Central</source><creator>Mahendrarajan, Venkatramanan ; Bari, Vinay Kumar</creator><creatorcontrib>Mahendrarajan, Venkatramanan ; Bari, Vinay Kumar</creatorcontrib><description>Candida albicans and its related species can cause opportunistic infections such as "candidiasis" in immunocompromised individuals with a high morbidity and mortality rate. Several antifungal drugs available in the market are often used to treat infections caused by pathogenic fungi. However, in fungi, the development of resistance against these drugs quickly evolved. Candida is a dimorphic fungus that can switch between yeast to hyphae form, requires an active biosynthesis of membrane constituents. Sphingolipid and ergosterol molecules, are the major fungal plasma membrane components, and their interaction with the antifungal drug can modulate drug susceptibility. A lipophilic compound farnesol acts as a quorum-sensing molecule synthesised by the isoprenoid biosynthesis pathway in the fungal pathogen Candida. Farnesol is secreted in a cell density-dependent manner inhibits hyphae germination and biofilm formation. In this study, we have investigated whether the farnesol molecules affect the drug susceptibility of the antifungal drug Amphotericin B (AmB) which mainly binds with ergosterol, and Aureobasidin A (AbA), a complex sphingolipid biosynthesis inhibitor. Our studies revealed that a non-toxic and low concentration of farnesol can reduce the efficacy of AmB and AbA on yeast cells. This reduction is probably through the alteration in the complex sphingolipid biosynthesis and ATP-binding cassette (ABC) type membrane transport activity. These findings may shed light on a new direction to explore the role of lipid molecules in the antifungal drug resistance mechanisms in pathogenic yeast.</description><identifier>ISSN: 2150-1203</identifier><identifier>EISSN: 2150-1211</identifier><identifier>DOI: 10.1080/21501203.2022.2138599</identifier><language>eng</language><publisher>Beijing: Taylor & Francis</publisher><subject>Amphotericin B ; Antifungal agents ; Aureobasidin A ; Biofilms ; Biosynthesis ; Candida ; Candidiasis ; Cell density ; Chemical synthesis ; Drug development ; Drug resistance ; Drugs ; Ergosterol ; Farnesol ; Fungi ; Fungicides ; Germination ; Hyphae ; Lipids ; Lipophilic ; Membranes ; Morbidity ; Sphingolipid biosynthesis ; Yeast ; Yeasts</subject><ispartof>Mycology, 2022-10, Vol.13 (4), p.305-317</ispartof><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022</rights><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c539t-79a4a0896f39ecc7b3ee5325282b8a338c473c16274c5531c40f737336eab6d73</citedby><cites>FETCH-LOGICAL-c539t-79a4a0896f39ecc7b3ee5325282b8a338c473c16274c5531c40f737336eab6d73</cites><orcidid>0000-0002-5670-3798</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673792/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3092107787?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27502,27924,27925,37012,37013,44590,53791,53793,59143,59144</link.rule.ids></links><search><creatorcontrib>Mahendrarajan, Venkatramanan</creatorcontrib><creatorcontrib>Bari, Vinay Kumar</creatorcontrib><title>A critical role of farnesol in the modulation of Amphotericin B and Aureobasidin A antifungal drug susceptibility</title><title>Mycology</title><description>Candida albicans and its related species can cause opportunistic infections such as "candidiasis" in immunocompromised individuals with a high morbidity and mortality rate. Several antifungal drugs available in the market are often used to treat infections caused by pathogenic fungi. However, in fungi, the development of resistance against these drugs quickly evolved. Candida is a dimorphic fungus that can switch between yeast to hyphae form, requires an active biosynthesis of membrane constituents. Sphingolipid and ergosterol molecules, are the major fungal plasma membrane components, and their interaction with the antifungal drug can modulate drug susceptibility. A lipophilic compound farnesol acts as a quorum-sensing molecule synthesised by the isoprenoid biosynthesis pathway in the fungal pathogen Candida. Farnesol is secreted in a cell density-dependent manner inhibits hyphae germination and biofilm formation. In this study, we have investigated whether the farnesol molecules affect the drug susceptibility of the antifungal drug Amphotericin B (AmB) which mainly binds with ergosterol, and Aureobasidin A (AbA), a complex sphingolipid biosynthesis inhibitor. Our studies revealed that a non-toxic and low concentration of farnesol can reduce the efficacy of AmB and AbA on yeast cells. This reduction is probably through the alteration in the complex sphingolipid biosynthesis and ATP-binding cassette (ABC) type membrane transport activity. These findings may shed light on a new direction to explore the role of lipid molecules in the antifungal drug resistance mechanisms in pathogenic yeast.</description><subject>Amphotericin B</subject><subject>Antifungal agents</subject><subject>Aureobasidin A</subject><subject>Biofilms</subject><subject>Biosynthesis</subject><subject>Candida</subject><subject>Candidiasis</subject><subject>Cell density</subject><subject>Chemical synthesis</subject><subject>Drug development</subject><subject>Drug resistance</subject><subject>Drugs</subject><subject>Ergosterol</subject><subject>Farnesol</subject><subject>Fungi</subject><subject>Fungicides</subject><subject>Germination</subject><subject>Hyphae</subject><subject>Lipids</subject><subject>Lipophilic</subject><subject>Membranes</subject><subject>Morbidity</subject><subject>Sphingolipid biosynthesis</subject><subject>Yeast</subject><subject>Yeasts</subject><issn>2150-1203</issn><issn>2150-1211</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk2LFDEQhhtRcFn3JwgBL15mzGencxHbxY-FBS96DtXp9EyGdDKbpJX596adcWE9mEvCW1VPqoq3aV4TvCW4w-8oEZhQzLYUU7qlhHVCqWfN1apvCCXk-eMbs5fNTc4HXA-jCrfiqnnokUmuOAMepegtihOaIAWbo0cuoLK3aI7j4qG4GNZoPx_3sdjkTA1_RBBG1C_JxgGyG6vUV6m4aQm7ihzTskN5ycYeixucd-X0qnkxgc_25nJfNz8-f_p--3Vz_-3L3W1_vzGCqbKRCjjgTrUTU9YYOTBrBaOCdnTogLHOcMkMaankRghGDMeTZJKx1sLQjpJdN3dn7hjhoI_JzZBOOoLTf4SYdhpSHdxbPRAOrZCE8lZyYrtBVA6eqMFCKCFMZb0_s47LMNvR2FAS-CfQp5Hg9noXf2rV1p4UrYC3F0CKD4vNRc-uLsV7CDYuWVPJOq44b0VNffNP6iEuKdRVaYYVJVjKbp1OnLNMijknOz02Q7BejaH_GkOvxtAXY9S6D-c6F6aYZvgVkx91gZOPaUoQjKvf_B_xG_cfvlk</recordid><startdate>20221002</startdate><enddate>20221002</enddate><creator>Mahendrarajan, Venkatramanan</creator><creator>Bari, Vinay Kumar</creator><general>Taylor & Francis</general><general>Taylor & Francis Ltd</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M7N</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5670-3798</orcidid></search><sort><creationdate>20221002</creationdate><title>A critical role of farnesol in the modulation of Amphotericin B and Aureobasidin A antifungal drug susceptibility</title><author>Mahendrarajan, Venkatramanan ; Bari, Vinay Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c539t-79a4a0896f39ecc7b3ee5325282b8a338c473c16274c5531c40f737336eab6d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Amphotericin B</topic><topic>Antifungal agents</topic><topic>Aureobasidin A</topic><topic>Biofilms</topic><topic>Biosynthesis</topic><topic>Candida</topic><topic>Candidiasis</topic><topic>Cell density</topic><topic>Chemical synthesis</topic><topic>Drug development</topic><topic>Drug resistance</topic><topic>Drugs</topic><topic>Ergosterol</topic><topic>Farnesol</topic><topic>Fungi</topic><topic>Fungicides</topic><topic>Germination</topic><topic>Hyphae</topic><topic>Lipids</topic><topic>Lipophilic</topic><topic>Membranes</topic><topic>Morbidity</topic><topic>Sphingolipid biosynthesis</topic><topic>Yeast</topic><topic>Yeasts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahendrarajan, Venkatramanan</creatorcontrib><creatorcontrib>Bari, Vinay Kumar</creatorcontrib><collection>Taylor & Francis Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Agricultural Science Collection</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Mycology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahendrarajan, Venkatramanan</au><au>Bari, Vinay Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A critical role of farnesol in the modulation of Amphotericin B and Aureobasidin A antifungal drug susceptibility</atitle><jtitle>Mycology</jtitle><date>2022-10-02</date><risdate>2022</risdate><volume>13</volume><issue>4</issue><spage>305</spage><epage>317</epage><pages>305-317</pages><issn>2150-1203</issn><eissn>2150-1211</eissn><abstract>Candida albicans and its related species can cause opportunistic infections such as "candidiasis" in immunocompromised individuals with a high morbidity and mortality rate. Several antifungal drugs available in the market are often used to treat infections caused by pathogenic fungi. However, in fungi, the development of resistance against these drugs quickly evolved. Candida is a dimorphic fungus that can switch between yeast to hyphae form, requires an active biosynthesis of membrane constituents. Sphingolipid and ergosterol molecules, are the major fungal plasma membrane components, and their interaction with the antifungal drug can modulate drug susceptibility. A lipophilic compound farnesol acts as a quorum-sensing molecule synthesised by the isoprenoid biosynthesis pathway in the fungal pathogen Candida. Farnesol is secreted in a cell density-dependent manner inhibits hyphae germination and biofilm formation. In this study, we have investigated whether the farnesol molecules affect the drug susceptibility of the antifungal drug Amphotericin B (AmB) which mainly binds with ergosterol, and Aureobasidin A (AbA), a complex sphingolipid biosynthesis inhibitor. Our studies revealed that a non-toxic and low concentration of farnesol can reduce the efficacy of AmB and AbA on yeast cells. This reduction is probably through the alteration in the complex sphingolipid biosynthesis and ATP-binding cassette (ABC) type membrane transport activity. These findings may shed light on a new direction to explore the role of lipid molecules in the antifungal drug resistance mechanisms in pathogenic yeast.</abstract><cop>Beijing</cop><pub>Taylor & Francis</pub><doi>10.1080/21501203.2022.2138599</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-5670-3798</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2150-1203 |
ispartof | Mycology, 2022-10, Vol.13 (4), p.305-317 |
issn | 2150-1203 2150-1211 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_b14a6571246741e8b57330f2c055955c |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); Taylor & Francis Journals; IngentaConnect Journals; PubMed Central |
subjects | Amphotericin B Antifungal agents Aureobasidin A Biofilms Biosynthesis Candida Candidiasis Cell density Chemical synthesis Drug development Drug resistance Drugs Ergosterol Farnesol Fungi Fungicides Germination Hyphae Lipids Lipophilic Membranes Morbidity Sphingolipid biosynthesis Yeast Yeasts |
title | A critical role of farnesol in the modulation of Amphotericin B and Aureobasidin A antifungal drug susceptibility |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A57%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20critical%20role%20of%20farnesol%20in%20the%20modulation%20of%20Amphotericin%20B%20and%20Aureobasidin%20A%20antifungal%20drug%20susceptibility&rft.jtitle=Mycology&rft.au=Mahendrarajan,%20Venkatramanan&rft.date=2022-10-02&rft.volume=13&rft.issue=4&rft.spage=305&rft.epage=317&rft.pages=305-317&rft.issn=2150-1203&rft.eissn=2150-1211&rft_id=info:doi/10.1080/21501203.2022.2138599&rft_dat=%3Cproquest_doaj_%3E3092107787%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c539t-79a4a0896f39ecc7b3ee5325282b8a338c473c16274c5531c40f737336eab6d73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3092107787&rft_id=info:pmid/&rfr_iscdi=true |